Last Updated: October 15, 2026

Patent: 11,466,090

✉ Email this page to a colleague

Summary for Patent: 11,466,090

Title:	Methods for treating or preventing migraine headache
Abstract:	The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.
Inventor(s):	Hong Sun, Eduardo Dunayevich, Robert A. Lenz, Gabriel Vargas
Assignee:	Amgen Inc
Application Number:	US16/287,533
Patent Claims:	see list of patent claims

Details for Patent 11,466,090

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amgen Inc.	AIMOVIG	erenumab-aooe	Injection	761077	May 17, 2018	⤷ Start Trial	2039-02-27
Amgen Inc.	AIMOVIG	erenumab-aooe	Injection	761077	March 11, 2019	⤷ Start Trial	2039-02-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,466,090

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201707179	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2016171742	⤷ Start Trial
United States of America	10259877	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.